MedTrace Logo

The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases

NCT00830401 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2015-06-04

No results posted yet for this study

Summary

This is a comparative, controlled trial to evaluate the impact of treating undetected, asymptomatic, predefined minor uterine cavity abnormalities on the success of IVF treatment.

Conditions

  • Minor Intra-uterine Abnormalities

Interventions

PROCEDURE

Treatment of predefined abnormality by hysteroscopic surgery

* Polyp resection with Hysteroscopic scissors or Versapoint * Resection of myoma with Resectoscope Storz or Versapoint * Septum resection with Resectoscope Storz or Versapoint * Resection of adhesions with Hysteroscopic scissors or Versapoint

DRUG

Ofloxacinum/Doxycycline

Treatment of endometrial inflammation: Ofloxacinum 400mg/day or Doxycyline 2x100mg on day one, followed by 100mg/day during 8 days.

Sponsors & Collaborators

  • AZ-VUB

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Bart CJM Fauser, Prof. dr. · UMC Utrecht

  • Paul Devroey, Prof. dr. · AZ-VUB

  • Frank JM Broekmans, Dr. · UMC Utrecht

  • Human M Fatemi, Dr. · AZ-VUB

  • Jenneke C Kasius · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-11-30
Completion
2009-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00830401 on ClinicalTrials.gov